Salmonella as a vaccine delivery vehicle
- PMID: 24053397
- PMCID: PMC3956298
- DOI: 10.1586/14760584.2013.825454
Salmonella as a vaccine delivery vehicle
Erratum in
- Expert Rev Vaccines. 2014 Mar;13(3):443
Abstract
Attenuated Salmonella vaccines can be administered orally to deliver recombinant antigens to mucosal surfaces inducing a protective immune response against a variety of targeted pathogens. A number of exciting new approaches and technologies for attenuated Salmonella vaccines have been developed recently. However, a disconnect remains between results obtained with mice in preclinical studies and results obtained in human clinical trials. This is due to an incomplete understanding of Salmonella Typhi interactions with human hosts and inadequate animal models available for study. In this review, the authors describe recent progress in identifying important differences underlying S. Typhi-host interactions, the development of novel approaches to vaccine design and six recent clinical trials evaluating Salmonella-vectored vaccines.
References
-
- Pasetti MF, Levine MM, Sztein MB. Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors. Vaccine. 2003;21(5–6):401–418. - PubMed
Websites
-
- IL-2 expressing attenuated Salmonella Typhimurium in unresectable hepatic spread. [accessed March 7, 2013]; http://www.clinicaltrials.gov/ct2/show/NCT01099631?term=salmonella+cance....
-
- Recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae PspA. [accessed March 7, 2013]; http://www.clinicaltrials.gov/ct2/show/NCT01033409?term=salmonella+pneum.... - PubMed
-
- Safety and immunogenicity of CVD 1902 oral attenuated vaccine to prevent S. Paratyphi A infection. [accessed March 7, 2013]; http://www.clinicaltrials.gov/ct2/show/NCT01129453?term=paratyphi+a&rank=1.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical